未登录

J

José M. Lanao

university of salamanca

H指数:23

被引数:3,383

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Building Artificial Neural Networks for the Optimization of Sustained-Release Kinetics of Metronidazole from Colonic Hydrophilic Matrices

构建人工神经网络以优化结肠亲水基质中甲硝唑的缓释动力学

IF5.5

2026-03-030

OAAI

In Silico Evaluation of the Biopharmaceutical and Pharmacokinetic Behavior of Metronidazole from Coated Colonic Release Matrix Tablets

体外模拟评估包衣结肠释放骨架片中甲硝唑的生物制药学和药代动力学行为

IF5.5

2025-05-140

OA

Hybrid nanosystems for the treatment of infectious diseases produced by multidrug-resistant bacteria: A systematic review

用于治疗由多重耐药细菌引起的感染性疾病的混合纳米系统：一篇系统综述

IF8.5

2025-04-080

OAAI

Development of intestinal colonic drug delivery systems for diverticular disease: A QbD approach

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2024-12-010

OA

Dosing Evaluation of Ceftazidime-Avibactam in Intensive Care Unit Patients Based on Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling and Simulation

ANTIBIOTICS-BASEL

IF4.6

2024-09-090

OA

Model-Informed Precision Dosing (MIPD)

IF5.5

2022-12-0611

OAAI

Physiologically Based Pharmacokinetic (PBPK) Model of Gold Nanoparticle-Based Drug Delivery System for Stavudine Biodistribution

IF5.5

2022-02-139

OAAI

Evaluation of Current Amikacin Dosing Recommendations and Development of an Interactive Nomogram: The Role of Albumin

当前阿米卡星剂量建议的评估和交互式诺模图的开发: 白蛋白的作用

IF5.5

2021-02-156

OAAI

Cell-Based Drug Delivery Platforms

IF5.5

2020-12-2210

OAAI

Advances in Exosomes-Based Drug Delivery Systems

基于外泌体的药物递送系统研究进展

MACROMOLECULAR BIOSCIENCE

IF4.1

2020-10-2261

PREAI

Amikacin initial dosage in patients with hypoalbuminaemia: an interactive tool based on a population pharmacokinetic approach

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2020-05-035

PREAI

Targeting of Hepatic Macrophages by Therapeutic Nanoparticles

FRONTIERS IN IMMUNOLOGY

IF5.9

2020-03-04106

OAAI

Enteric coating of oral solid dosage forms as a tool to improve drug bioavailability

口服固体制剂的肠溶包衣作为提高药物生物利用度的手段

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2019-10-0186

PREAI

Evaluation of renal function equations to predict amikacin clearance

EXPERT REVIEW OF CLINICAL PHARMACOLOGY

IF3

2019-07-227

PREAI

Pharmacokinetics and dosing requirements of digoxin in pregnant women treated for fetal supraventricular tachycardia

EXPERT REVIEW OF CLINICAL PHARMACOLOGY

IF3

2017-07-0613

PREAI

Gold Nanocarriers for Macrophage-Targeted Therapy of Human Immunodeficiency Virus

MACROMOLECULAR BIOSCIENCE

IF4.1

2016-10-1721

PREAI

Approaches for dosage individualisation in critically ill patients

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY

IF3.4

2013-07-3111

PREAI

International seminar on the red blood cells as vehicles for drugs

EXPERT OPINION ON BIOLOGICAL THERAPY

IF4

2011-10-2588

OA

Optimization of Release Kinetics from Sustained-Release Formulations using Model-Independent Pharmacokinetic Simulation

使用与模型无关的药代动力学模拟优化缓释制剂的释放动力学

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2011-08-015

PREAI

Study of the factors influencing the encapsulation of zidovudine in rat erythrocytes

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2010-11-0115

PREAI